Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

230 results about "Amidoamine" patented technology

Amidoamines are a class of chemical compounds that are formed from fatty acids and diamines. They are used as intermediates in the synthesis of surfactants, such as cocamidopropyl betaine (CAPB), some of which are used in personal care products including soaps, shampoos, and cosmetics. Amidoamines can also serve as curing agents for epoxy resins.

Quaternized fatty amines, amidoamines and their derivatives from natural oil metathesis

Quaternary ammonium, betaine, or sulfobetaine compositions derived from fatty amines, wherein the fatty amine is made by reducing the amide reaction product of a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives and a secondary amine, are disclosed. Quaternary ammonium, betaine, or sulfobetaine compositions derived from fatty amidoamines, wherein the amidoamine is made by reacting of a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives and an aminoalkyl-substituted tertiary amine, are also disclosed. The quaternized compositions are advantageously sulfonated or sulfated. In one aspect, the ester derivative of the C10-C17 monoun-saturated acid or octadecene-1,18-dioic acid is a lower alkyl ester. In other aspects, the ester derivative is a modified triglyceride made by self-metathesis of a natural oil or an unsaturated triglyceride made by cross-metathesis of a natural oil with an olefin. The quaternary ammonium, betaine, and sulfobetaine compositions and their sulfonated or sulfated derivatives are valuable for a wide variety of end uses, including cleaners, fabric treatment, hair conditioning, personal care (liquid cleansing products, conditioning bars, oral care products), antimicrobial compositions, agricultural uses, and oil field applications.
Owner:STEPAN COMPANY

Preparation of CT/MRI dual-modality imaging contrast agent based on dendrimer

The invention relates to a method for preparing a computed tomography (CT)/magnatic resonance imaging (MRI) bimodal imaging contrast agent based on dendrimers. The method comprises the following steps of: (1) adding DOTA-N-hydroxy succinimide (NHS) solution into the fifth generation of poly(amidoamine) (PAMAM) dendrimer solution, adding methoxy poly(ethylene glycol) (mPEG)-COOH solution which is subjected to 1-ethy 1-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) activation, reacting with stirring, and thus obtaining functionalized dendrimer solution; (2) adding chloroauric acid solution and sodium borohydride solution into the functionalized dendrimer solution, reacting with stirring, adding gadolinium nitrate solution, stirring, adding triethylamine and acetic anhydride, andreacting with stirring for 8 to 24 hours; and (3) dialyzing the solution obtained in the step (2), performing freeze drying treatment, and thus obtaining the contrast agent. The method has a simple preparation process, and experimental conditions are realized at normal temperature and under normal pressure; and the CT/MRI bimodal imaging contrast agent prepared by the method has a good CT/MRI effect, and a favorable foundation is laid for the development of a novel multifunctional contrast agent.
Owner:DONGHUA UNIV

Antidaudruff hair conditioning composition

Disclosed is hair conditioning compositions comprising antidandruff agent wherein the hair conditioning composition is substantially free of the group selected from a chelating agent, methylchloroisothiazolinone, and methylisothiazolinone. The compositions comprise by weight: (a) from about 0.1 % to about 15 % of a high melting point fatty compound; (b) compounds selected of; (b1a) from about 0.1 % to about 10 % of an amidoamine having the following general formula: R<1> CONH (CH2)m N(R<2>)2 wherein R<1> is a residue of C11 to C24 fatty acids, R<2> is a C1 to C4 alkyl, and m is an integer from 1 to 4; (b1b) an acid selected from the group consisting of 1 glutamic acid, lactic acid, hydrochloric acid, malic acid, acetic acid, fumaric acid, 1 glutamic acid hydrochloride, tartaric acid, and mixtures thereof, at a level such that the mole ratio of amidoamine to acid is from about 1:0.3 to about 1:1; or (b2) the combination of; (b2a) from about 0.1% to about 10% of a cationic conditioning agent; and (b2b) from about 0.1% to about 10% of a low melting point oil having a melting point of less than 25 DEG C; (c) a safe and effective amount of an antidandruff agent; (e) a preservative system comprising, by weight of the entire composition, from about 0.1% to about 1.0% of benzyl alcohol, from about 0.1 % to about 1.0 % of phenoxy ethanol, from about 0.05 % to about 1.0 % of methyl paraben, and from about 0.05 % to about 1.0 % of mettryl paraben, and from about 0.01 % to about 1.0 % of propyl paraben; and (f) an aqueous carrier.
Owner:THE PROCTER & GAMBLE COMPANY

Method for preparing poly(amidoamine)/carbon nanometer tube composite material for cancer cell targeting diagnosis

The invention relates to a method for preparing a poly (amidoamine) dendritic polymer/carbon nanometer tube composite material for cancer cell targeting diagnosis. The method comprises that: a carbon nanometer tube CNT is subjected to acidizing treatment; fluorescein isothiocyanate FI and folic acid FA of the poly(amidoamine) dendritic polymer are modified; a CNT composite is obtained through an EDC chemical bonding method and a carboxyl reaction on the surface of a multi-walled carbon nanometer tube which is subjected to the acidizing treatment; terminal amino and acetyl oxide of the rest dendritic polymer on the surface of the composite are subjected to acetylation reaction to obtain a functional composite carbon nanometer tube with neutral surface charge. The functional carbon nanometer tube can be scattered in a solvent for a long time without agglomeration, and the functional multi-walled carbon nanometer tube has good biocompatibility, can be combined on the cancer cell in a targeting manner, and can be used for early-stage target diagnosis of the cancer cell; the method has the advantages of simple preparation method, mild reaction condition and easy operation, and the used polymer is an environment-friendly polymer material, and has industrial implementation prospect.
Owner:DONGHUA UNIV

Method for gene transfection by utilizing PEG (polyethylene glycol) functionalized PAMAM (poly(amidoamine)) dendrimer carrier encapsulating gold nanoparticles

The invention relates to a method for gene transfection by utilizing a PEG (polyethylene glycol) functionalized PAMAM (poly(amidoamine)) dendrimer carrier encapsulating gold nanoparticles. The method comprises the following steps: (1) preparing an activated mPEG (methoxypolyethylene glycol) solution, weighing a fifth-generation PAMAM dendrimer and dissolving the fifth-generation PAMAM dendrimer in DMSO (dimethyl sulfoxide), then adding the activated mPEG solution and carrying out magnetic stirring under room temperature to react to obtain a G5.NH2-mPEG10 solution; (2) dropwise adding an HAuCl4 aqueous solution to the G5.NH2-mPEG10 solution and quickly adding a NaBH4 solution after stirring to obtain a reaction product; (3) preparing a carrier/gene compound solution with the reaction product and pDNA (plasmid deoxyribonucleic acid) or siRNA (small interfering ribonucleic acid); (4) carrying out cell transfection by adopting the carrier/gene compound solution. The prepared carrier has the advantages of mild transfection conditions, easiness in operation, high transfection efficiency, good specificity and the like when being used for gene transfection and has good application prospect in cancer therapy and the like.
Owner:DONGHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products